Zarnestra

DRUG2 trials

Sponsors

Institut Claudius Regaud

Conditions

Breast NeoplasmsGlioblastoma Multiforme

Phase 2

Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer

TerminatedNCT00210028

Institut Claudius RegaudBreast Neoplasms

Start: 2003-08-31End: 2008-08-31Target: 40Updated: 2006-11-14

Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme

CompletedNCT00209989

Institut Claudius RegaudGlioblastoma Multiforme

Start: 2005-10-01End: 2011-06-01Updated: 2026-06-26